Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

When a hearing aid isn’t enough

23

Oct 2025

When a hearing aid isn’t enough

Kitty Grutzmacher had contended with poor hearing for a decade, but the problem had worsened over the past year. Even with her hearing aids, "there was little or no sound," she said.

Can introducing peanuts early prevent allergies? Real-world data confirms it helps

22

Oct 2025

Can introducing peanuts early prevent allergies? Real-world data confirms it helps

Using data from over 120,000 U.S. children, this Pediatrics study found that the prevalence and risk of peanut and other IgE-mediated food allergies declined significantly after the 2015 and 2017 guidelines promoting early allergen introduction. The findings support these policies as effective public health measures to prevent food allergies in real-world settings.

AI-driven eye screening aims to close the diabetic vision gap in community clinics

22

Oct 2025

AI-driven eye screening aims to close the diabetic vision gap in community clinics

A new trial will evaluate whether integrating autonomous AI screening for diabetic retinopathy into U.S. federally qualified health centers can boost screening completion and accelerate early detection. The DRES-POCAI protocol tests a real-world, point-of-care model that links FDA-cleared AI with electronic health records to close gaps in diabetes eye care.

Mediterranean diet linked to dramatically lower odds of endometriosis

22

Oct 2025

Mediterranean diet linked to dramatically lower odds of endometriosis

A new case–control study found that women with stronger adherence to the Mediterranean diet had dramatically lower odds of endometriosis. Diets rich in fruits, vegetables, fish, and legumes were protective, while higher intakes of meat, dairy, and refined whole grains were linked to increased risk.

Female bodybuilders face higher risk of sudden cardiac death, study reveals

22

Oct 2025

Female bodybuilders face higher risk of sudden cardiac death, study reveals

A 16-year study in the European Heart Journal found that sudden cardiac death (SCD) was the leading cause of death among female bodybuilding athletes. While overall mortality was half that of men, women still had a markedly higher SCD risk than other female athletes, highlighting the need for stricter health oversight and PED monitoring.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.